What a 19% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
Archive — August 2025
Page 4 of 5 of this archive, newest first.
VendorInvestigate result on a Shenzhen dulaglutide lot lands 2.0 points above the supplier’s stated figure
A reminder that a purity figure is the output of a method, and that methods differ.
The online reseller trading as Adamant Research Supply closes after 17 years
A proper account of an operation that existed, and of what closing it cost.
Priming a pen is not optional
For licensed products the in-use period is established by stability data. For a peptide reconstituted at home there is no such data, and the honest answer is that nobody…
The badge economy, and what it is actually certifying
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
Independent analysis puts a SWB tirzepatide lot at 95.6%, against 93.1% on the certificate
The result is unremarkable. What the report states alongside it is not.
Shanghai export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
What the new Denmark guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Inspectors cite the consolidator trading as Meridian Freight Partners over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Where the solvent front ends is a decision, not a fact
The denominator excludes solvent-front features and injection artefacts by convention. Conventions differ on where the front ends, and a fragment eluting early exists in one…
Rapid weight loss moves eight analytes for reasons that have nothing to do with the drug
A substantial proportion of the abnormal results generated during rapid weight loss are consequences of the weight loss rather than findings about the person.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 24% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
A supplier suspends shipping to South Korea after 10 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Bacteriostatic water, sterile water, and the 0.9 per cent that makes the difference
At low concentrations a measurable fraction of peptide can adsorb to glass and plastic surfaces, and the loss is largest exactly where it is least expected.
Who signed this, and what did they undertake by signing it
A manufacturer’s certificate is a self-declaration. An accredited laboratory’s report is a third-party measurement. The trade prints both under one heading.
The advice is mostly reasonable. The certainty is not earned.
Grading six widely repeated claims against the studies actually behind them.
Nigeria pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Calder Vale Peptides of Skipton closes after 8 years
A proper account of an operation that existed, and of what closing it cost.
Escalating past the approved maximum, examined honestly
Higher doses of these molecules have been studied. In general they produced modest additional efficacy and disproportionate additional symptom burden, which is why the…
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
SURPASS-4 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Singapore caps semaglutide prescribing to 10 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
Six lines that would make an identity statement checkable
What the Journal asks for when it writes to a supplier about an identity claim, and how often it gets it.
What a batch number is supposed to mean
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.
The United Arab Emirates pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
WXT names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Saudi Arabia declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Calder Vale Peptides of Skipton closes after 21 years
A proper account of an operation that existed, and of what closing it cost.
Vitamin D, adiposity, and a volume-of-distribution problem
Which markers are informative, which are confounded, and which move for reasons unrelated to nutrition.
What happens when the drug is taken away: three randomised answers
The regain trajectories, arm by arm, with the estimands named.
The 30-day notice: how a compounding wind-down works in Switzerland
The document is four pages. Three of them are about dates.
The online reseller trading as Adamant Research Supply closes after 23 years
A proper account of an operation that existed, and of what closing it cost.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
What a batch number is supposed to mean
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.
Why "muscle-sparing" is a marketing term and not a measurement
A tour of the source literatures, with an assessment of how far each legitimately reaches.
A shortage listing ends. 21 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.